← FDA DRUG APPROVALS
FDA ANDA · ANDA201745
ACID REDUCER
ranitidine hydrochloride
Sponsor: STRIDES PHARMA
APPLICATION
ANDA201745
TYPE
ANDA
ORIGINAL APPROVAL
2012-02-29
LATEST ACTION
2012-02-29
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
RANITIDINE HYDROCHLORIDEDiscontinued
RANITIDINE HYDROCHLORIDE EQ 75MG BASE · TABLET · ORAL
Approval history
2012-02-29Not Applicable · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.